Trials / Conditions / Allogeneic Hematopoietic Stem Cell Transplant Recipient
Allogeneic Hematopoietic Stem Cell Transplant Recipient
5 registered clinical trials studyying Allogeneic Hematopoietic Stem Cell Transplant Recipient.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Suspended | Human Lysozyme Goat Milk for the Prevention of Graft Versus Host Disease in Patients With Blood Cancer Undergo NCT04177004 | City of Hope Medical Center | Phase 1 |
| Active Not Recruiting | Blood Samples to Identify Biomarkers in Patients Treated With Cyclophosphamide After Donor Stem Cell Transplan NCT04160390 | City of Hope Medical Center | — |
| Active Not Recruiting | Gardasil 9 Vaccine in Preventing HPV Infection in Patients With Hematologic Malignancies Undergoing Donor Stem NCT03023631 | M.D. Anderson Cancer Center | Phase 4 |
| Completed | Selective Depletion of CD45RA+ T Cells From Allogeneic Peripheral Blood Stem Cell Grafts From HLA-Matched Rela NCT02220985 | Fred Hutchinson Cancer Center | Phase 2 |
| Completed | Ipilimumab or Nivolumab in Treating Patients With Relapsed Hematologic Malignancies After Donor Stem Cell Tran NCT01822509 | National Cancer Institute (NCI) | Phase 1 |